New onset refractory status epilepticus (NORSE)

Brief description of study

This is a multi-site study aiming at creating a biorepository of a rare disease, new onset refractory status epilepticus (NORSE), to establish clinical characteristics, outcomes and biomarkers of disease.


Clinical Study Identifier: s18-01938
Principal Investigator: Claude Steriade.
Other Investigator: Amy C. Jongeling.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.